1. O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle
   John A. Hanover et al, 2018, Journal of Bioenergetics and Biomembranes CrossRef
2. Blocking ATM Attenuates SKOV3 Cell Proliferation and Migration by Disturbing OGT/OGA Expression via hsa-miR-542-5p
   Ning Wang et al, 2022, Frontiers in Oncology CrossRef
3. Role of O-GlcNAcylation in cancer biology
   Yuxuan Li et al, 2024, Pathology - Research and Practice CrossRef
4. MicroRNA-7-5p′s role in the O-GlcNAcylation and cancer metabolism
   Sin Yung Woo et al, 2020, Non-coding RNA Research CrossRef
5. A living cell-based fluorescent reporter for high-throughput screening of anti-tumor drugs
   Ningning Tang et al, 2021, Journal of Pharmaceutical Analysis CrossRef
6. Simulated microgravity inhibits cell focal adhesions leading to reduced melanoma cell proliferation and metastasis via FAK/RhoA-regulated mTORC1 and AMPK pathways
   Xin Tan et al, 2018, Scientific Reports CrossRef
7. The O-GlcNAc Modification on Kinases
   Paul A. Schwein et al, 2020, ACS Chemical Biology CrossRef
8. Checkpoint kinase 1–induced phosphorylation of O-linked β-N-acetylglucosamine transferase regulates the intermediate filament network during cytokinesis
   Zhe Li et al, 2017, Journal of Biological Chemistry CrossRef
9. The mechanism of total ginseng extracts in the treatment of lung cancer progression based on network pharmacology and experimental validation
   Zhong-Hong Wei et al, 2023, World Journal of Traditional Chinese Medicine CrossRef
10. O-GlcNAcylation in cancer development and immunotherapy
    Xue-Fen He et al, 2023, Cancer Letters CrossRef
11. Role of Hexosamine Biosynthetic Pathway on Cancer Stem Cells: Connecting Nutrient Sensing to Cancer Cell Plasticity
    Giang Le Minh et al, 2022, Comprehensive Pharmacology CrossRef
12. Targeted Inhibition of O-Linked β-N-Acetylglucosamine Transferase as a Promising Therapeutic Strategy to Restore Chemosensitivity and Attenuate Aggressive Tumor Traits in Chemoresistant Urothelial Carcinoma of the Bladder
    Hye Lee et al, 2022, Biomedicines CrossRef
13. O-Glycosylation with O-linked β-N-acetylglucosamine increases vascular contraction: Possible modulatory role on Interleukin-10 signaling pathway
    Jéssica S.G. Miguez et al, 2018, Life Sciences CrossRef
14. O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy
    Qingsong Lu et al, 2022, Molecular Medicine CrossRef
15. Quercetin induces cell death in cervical cancer by reducing O-GlcNAcylation of adenosine monophosphate-activated protein kinase
    Akhtar Ali et al, 2018, Anatomy & Cell Biology CrossRef
16. The hexosamine biosynthetic pathway and cancer: Current knowledge and future therapeutic strategies
    Christine Lam et al, 2021, Cancer Letters CrossRef
17. The O-GlcNAc dichotomy: when does adaptation become pathological?
    Tiago J. Costa et al, 2023, Clinical Science CrossRef
18. Quantitative proteomic analysis of the association between decreasing O‑GlcNAcylation and metastasis in MCF‑7 breast cancer cells
    Pukkavadee Netsirisawan et al, 2020, International Journal of Oncology CrossRef
19. O-GlcNAcylation in women’s cancers: breast, endometrial and ovarian
    Gloria M. Trinca et al, 2018, Journal of Bioenergetics and Biomembranes CrossRef
20. Relationship Between O-GlcNAcase Expression and Prognosis of Patients With Osteosarcoma
    Thamonwan Sombutthaweesri et al, 2022, Applied Immunohistochemistry & Molecular Morphology CrossRef